STOCK TITAN

CAMDEN NATIONAL CORP (CAC) SEC Filings

CAC NASDAQ
Rhea-AI Summary

Camden National Corporation (CAC) declared a quarterly dividend of $0.42 per share, payable October 30, 2026, to shareholders of record at the close of business October 15, 2026. The company stated that the dividend represents an annualized yield of 2.93%, based on the September 28, 2026 closing share price of $57.40.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) reported that director Raina Maxwell received a grant of 249 shares of common stock on September 18, 2026 as a stock award in lieu of director fees under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment. The filing also notes an additional 28.935 shares accumulated since the prior report through participation in the company's dividend reinvestment program, bringing Maxwell's directly held common stock to a total of 4,310.753 shares after these acquisitions. No transactions are reported under a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) director Rebecca Hatfield reported an acquisition of company stock through compensation-related awards. On September 18, 2026, she received 152 shares of Common Stock at $57.55 per share as a grant under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees. A footnote also states that her holdings include 0.352 additional shares acquired since the last filing through participation in the company's dividend reinvestment program, bringing her direct ownership to 8,783.797 shares after the reported transactions. No transactions were reported under a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) director Carl John Soderberg reported receiving a grant of 275 shares of Common Stock on September 18, 2026. The shares were acquired at a reported value of $57.55 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees. Following this award, he directly holds 104,624.218 shares of Camden National common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CAMDEN NATIONAL CORP (symbol: CAC) is the issuer of record for a Form 4 filing submitted to the SEC. Haynes Larry K reported acquisition or exercise transactions in this Form 4 filing.

CAMDEN NATIONAL CORP (CAC) reported that director Larry K. Haynes received a grant of 249 shares of Common Stock on September 18, 2026 at a value of $57.55 per share. The shares were awarded under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, and no Rule 10b5-1 trading plan is reported. After this award, he held 1,447 shares directly and 3,217.888 shares indirectly through a revocable trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

CAMDEN NATIONAL CORP (symbol: CAC) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

CAMDEN NATIONAL CORP (CAC) reported that EVP Joshua M. Nash acquired equity-based awards in the form of common stock on August 14, 2026. He received 632 and 834 shares of restricted stock awards and 246 restricted stock units under the company’s 2022 Equity and Incentive Plan and Amendment. These awards vest pro-rata over their respective service periods, subject to continued employment, with each award or unit converting into one share of common stock at vesting. Following these grants, Nash’s equity includes 5,191 restricted stock units and restricted shares subject to vesting and forfeiture restrictions, and there is also an indirect holding of 1,682.799 shares of common stock held by his spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 1,330,676.75 shares of CAMDEN NATIONAL CORP common stock, representing 7.9% of the class. FMR LLC reports sole voting power over 1,330,065 shares and sole dispositive power over 1,330,676.75 shares, with no shared voting or dispositive power.

Abigail P. Johnson is also reported as a beneficial owner with 1,330,676.75 shares, holding sole dispositive power but no voting power. One or more other persons have rights to receive dividends or sale proceeds from these shares, but no such person has more than 5% of the outstanding common stock. Subsidiaries through which the holdings are made are identified in an attached exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Camden National Corporation reported stronger results for the quarter ended June 30, 2026. Net income was $23,021 thousand, up from $14,081 thousand a year earlier, as net interest income rose to $52,939 thousand and the provision for credit losses dropped to $710 thousand from $6,920 thousand. Quarterly basic earnings per share increased to $1.36 from $0.84, while cash dividends per share remained $0.42.

For the first six months of 2026, net income reached $44,904 thousand versus $21,407 thousand in 2025, with basic EPS of $2.65. Total assets were $6,950,980 thousand and loans $5,004,468 thousand as of June 30, 2026. Deposits totaled $5,555,104 thousand, and shareholders’ equity increased to $725,926 thousand, reflecting retained earnings and modest share repurchases. The allowance for credit losses on loans was $45,604 thousand, while sizable unrealized losses on available-for-sale and held-to-maturity securities remained largely tied to interest rate movements rather than credit concerns.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Camden National Corp executive Joshua M. Nash, EVP, filed an initial statement of beneficial ownership of common stock. He reports 9,159.6300 shares held directly, including 3,479 restricted stock units subject to vesting and forfeiture, and 1,682.7990 shares held indirectly through his spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many CAMDEN NATIONAL (CAC) SEC filings are available on StockTitan?

StockTitan tracks 140 SEC filings for CAMDEN NATIONAL (CAC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CAMDEN NATIONAL (CAC)?

The most recent SEC filing for CAMDEN NATIONAL (CAC) was filed on September 29, 2026.